Concepedia

Kumaravel Mohankumar

KM

Statistics

Publications

22

Citations

636

H-Index

18

Active since

2014

Affiliations

Texas A&M University(Current)

Baylor College of Medicine

Kumaravel Mohankumar is an author at Texas A&M University specializing in medicine, pharmacology, and molecular oncology.

Publications per year

2014–2023

22

Publications

22

Aryl hydrocarbon receptor (AhR) ligands as selective AhR modulators: Genomic studies

Stephen Safe, Huajun Han, Jennifer S. Goldsby et al. · Current Opinion in Toxicology · 2018 · 66 citations · Full text

, , +14

Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth

Rupesh Shrestha, Kumaravel Mohankumar, Greg Martin et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 53 citations · Full text

, , +13

A Bis-Indole–Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity

Keshav Karki, Gus A. Wright, Kumaravel Mohankumar et al. · Cancer Research · 2020 · 41 citations · Full text

, , +17

Orphan nuclear receptor 4A1 (NR4A1) and novel ligands

Stephen Safe, Rupesh Shrestha, Kumaravel Mohankumar · Essays in Biochemistry · 2021 · 41 citations · Full text

, , +16

Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists

Erik Hedrick, Xi Li, Yating Cheng et al. · Breast Cancer Research and Treatment · 2019 · 34 citations · Full text

, , +11

1–5 of 22